Investigators developed a lipid nanoparticle-formulated mRNA-based T cell-inducing antigen, which targeted three SARS-CoV-2 proteome regions that enriched human HLA-I epitopes.
[Nature Communications]
Home Newsletters Immunology of Infectious Disease News An mRNA-Based T Cell-Inducing Antigen Strengthens COVID-19 Vaccine against SARS-CoV-2 Variants
